HomeCompareLIXTW vs GIS

LIXTW vs GIS: Dividend Comparison 2026

LIXTW yields 9049.77% · GIS yields 6.55%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LIXTW wins by $20628078872155540.00M in total portfolio value
10 years
LIXTW
LIXTW
● Live price
9049.77%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20628078872155540.00M
Annual income
$20,189,225,229,131,710,000,000.00
Full LIXTW calculator →
GIS
GIS
● Live price
6.55%
Share price
$37.11
Annual div
$2.43
5Y div CAGR
22.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$79.2K
Annual income
$16,311.42
Full GIS calculator →

Portfolio growth — LIXTW vs GIS

📍 LIXTW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLIXTWGIS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LIXTW + GIS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LIXTW pays
GIS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LIXTW
Annual income on $10K today (after 15% tax)
$769,230.77/yr
After 10yr DRIP, annual income (after tax)
$17,160,841,444,761,954,000,000.00/yr
GIS
Annual income on $10K today (after 15% tax)
$556.59/yr
After 10yr DRIP, annual income (after tax)
$13,864.71/yr
At 15% tax rate, LIXTW beats the other by $17,160,841,444,761,954,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LIXTW + GIS for your $10,000?

LIXTW: 50%GIS: 50%
100% GIS50/50100% LIXTW
Portfolio after 10yr
$10314039436077770.00M
Annual income
$10,094,612,614,565,855,000,000.00/yr
Blended yield
97.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GIS right now

LIXTW
No analyst data
Altman Z
-15.6
Piotroski
2/9
GIS
Analyst Ratings
9
Buy
19
Hold
6
Sell
Consensus: Hold
Price Target
$47.42
+27.8% upside vs current
Range: $35.00 — $63.00
Altman Z
2.2
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LIXTW buys
0
GIS buys
0
No recent congressional trades found for LIXTW or GIS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLIXTWGIS
Forward yield9049.77%6.55%
Annual dividend / share$2.00$2.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.8%
Portfolio after 10y$20628078872155540.00M$79.2K
Annual income after 10y$20,189,225,229,131,710,000,000.00$16,311.42
Total dividends collected$20598825129197092.00M$51.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: LIXTW vs GIS ($10,000, DRIP)

YearLIXTW PortfolioLIXTW Income/yrGIS PortfolioGIS Income/yrGap
1← crossover$915,677$904,977.38$11,504$804.11+$904.2KLIXTW
2$78,425,318$77,445,542.82$13,371$1,061.65+$78.41MLIXTW
3$6,282,983,839$6,199,068,749.48$15,723$1,416.15+$6282.97MLIXTW
4$470,866,355,476$464,143,562,767.87$18,735$1,911.16+$470866.34MLIXTW
5$33,012,577,055,280$32,508,750,054,920.79$22,660$2,613.51+$33012577.03MLIXTW
6$2,165,414,967,816,058$2,130,091,510,366,908.20$27,874$3,627.81+$2165414967.79MLIXTW
7$132,896,851,494,306,460$130,579,857,478,743,280.00$34,947$5,121.52+$132896851494.27MLIXTW
8$7,631,926,324,796,117,000$7,489,726,693,697,209,000.00$44,762$7,369.21+$7631926324796.07MLIXTW
9$410,143,591,611,054,950,000$401,977,430,443,523,100,000.00$58,728$10,832.80+$410143591611054.88MLIXTW
10$20,628,078,872,155,540,000,000$20,189,225,229,131,710,000,000.00$79,151$16,311.42+$20628078872155540.00MLIXTW

LIXTW vs GIS: Complete Analysis 2026

LIXTWStock

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.

Full LIXTW Calculator →

GISConsumer Staples

General Mills, Inc. manufactures and markets branded consumer foods worldwide. The company operates in five segments: North America Retail; Convenience Stores & Foodservice; Europe & Australia; Asia & Latin America; and Pet. It offers ready-to-eat cereals, refrigerated yogurt, soup, meal kits, refrigerated and frozen dough products, dessert and baking mixes, bakery flour, frozen pizza and pizza snacks, snack bars, fruit and salty snacks, ice cream, nutrition bars, wellness beverages, and savory and grain snacks, as well as various organic products, including frozen and shelf-stable vegetables. It also supplies branded and unbranded food products to the North American foodservice and commercial baking industries; and manufactures and markets pet food products, including dog and cat food. The company markets its products under the Annie's, Betty Crocker, Bisquick, Blue Buffalo, Blue Basics, Blue Freedom, Bugles, Cascadian Farm, Cheerios, Chex, Cinnamon Toast Crunch, Cocoa Puffs, Cookie Crisp, EPIC, Fiber One, Food Should Taste Good, Fruit by the Foot, Fruit Gushers, Fruit Roll-Ups, Gardetto's, Go-Gurt, Gold Medal, Golden Grahams, Häagen-Dazs, Helpers, Jus-Rol, Kitano, Kix, Lärabar, Latina, Liberté, Lucky Charms, Muir Glen, Nature Valley, Oatmeal Crisp, Old El Paso, Oui, Pillsbury, Progresso, Raisin Nut Bran, Total, Totino's, Trix, Wanchai Ferry, Wheaties, Wilderness, Yoki, and Yoplait trademarks. It sells its products directly, as well as through broker and distribution arrangements to grocery stores, mass merchandisers, membership stores, natural food chains, e-commerce retailers, commercial and noncommercial foodservice distributors and operators, restaurants, convenience stores, and pet specialty stores, as well as drug, dollar, and discount chains. The company operates 466 leased and 392 franchise ice cream parlors. General Mills, Inc. was founded in 1866 and is headquartered in Minneapolis, Minnesota.

Full GIS Calculator →
📬

Get this LIXTW vs GIS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LIXTW vs SCHDLIXTW vs JEPILIXTW vs OLIXTW vs KOLIXTW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.